Free Trial
ASX:CT1

Constellation Technologies (CT1) Stock Price, News & Analysis

Constellation Technologies logo

About Constellation Technologies Stock (ASX:CT1)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
983,646 shs
Average Volume
N/A
Market Capitalization
A$1.47 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CT1 Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Constellation Technologies and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CT1 Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.tc pixel
Constellation Technologies Limited
See More Headlines

CT1 Stock Analysis - Frequently Asked Questions

Constellation Technologies Limited (ASX:CT1) issued its quarterly earnings data on Thursday, February, 28th. The company reported $0.00 earnings per share for the quarter. Constellation Technologies had a negative net margin of 9.04% and a negative trailing twelve-month return on equity of 13.35%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Constellation Technologies investors own include Neuren Pharmaceuticals (NEU), Macquarie Group (MQG), Magellan Financial Group (MFG), Medlab Clinical (MDC), FBR (FBR), Embark Early Education (EVO) and Dreadnought Resources (DRE).

Company Calendar

Last Earnings
2/28/2019
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Industry
Information Technology Services
Sub-Industry
N/A
Current Symbol
ASX:CT1
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
-9.04%
Pretax Margin
N/A
Return on Equity
-13.35%
Return on Assets
-5.93%

Debt

Debt-to-Equity Ratio
13.79
Current Ratio
2.62
Quick Ratio
3.30

Sales & Book Value

Annual Sales
A$1.35 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
5.63
Book Value
A$0.00 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
1,470,000,000
Free Float
N/A
Market Cap
A$1.47 million
Optionable
Not Optionable
Beta
1.40
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:CT1) was last updated on 9/8/2025 by MarketBeat.com Staff
From Our Partners